Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3229217 | 0.79 | LMNA (0.50) | LMNATSHRMAPK1TDP1CYP3A4 | |
| SCHEMBL6021854 | 0.79 | ZDHHC20 (0.47) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| SCHEMBL3229211 | 0.79 | LMNA (0.50) | LMNATSHRMAPK1TDP1CYP3A4 | |
| SCHEMBL23278488 | 0.77 | ZDHHC20 (0.46) | LMNAZDHHC20ZDHHC2TSHRALDH1A1 | |
| SCHEMBL6290124 | 0.77 | LMNA (0.48) | LMNATDP1 | |
| SCHEMBL442584 | 0.77 | LMNA (0.44) | LMNA | |
| SCHEMBL6280191 | 0.76 | LMNA (0.47) | LMNA | |
| SCHEMBL6284139 | 0.76 | LMNA (0.47) | LMNATDP1 | |
| SCHEMBL17183770 | 0.75 | ZDHHC20 (0.47) | ZDHHC20ZDHHC2TSHRALDH1A1MAPK1 | |
| SCHEMBL16060 | 0.74 | TSHR (0.48) | LMNAZDHHC20ZDHHC2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021191175-A1 | DETERGENT FORMULATION IN FORM OF A THREE DIMENSIONAL BODY | BASF SE (DE) | 2021-09-30 | — | — | WO | disclosed |
| EP-3555153-B1 | MULTI-LAYER FILMS, METHOD FOR ITS MANUFACTURE AND ITS USE | BASF SE (DE) | 2020-12-09 | — | — | EP | disclosed |
| EP-3746488-A1 | A PROCESS FOR THE PREPARATION OF A POLYMER COMPOSITION | BASF SE (DE) | 2020-12-09 | — | — | EP | disclosed |
| US-20200362070-A1 | A Process for the Preparation of a Polymer Composition | BASF SE (DE) | 2020-11-19 | — | — | US | disclosed |
| WO-2020224962-A1 | WATER-SOLUBLE FILMS WITH THREE-DIMENSIONAL TOPOGRAPHY | BASF SE (DE) | 2020-11-12 | — | — | WO | disclosed |
| EP-3555182-B1 | METHOD FOR PRODUCING FUNCTIONAL WATER SOLUBLE FILMS | BASF SE (DE) | 2020-10-14 | — | — | EP | disclosed |
| CN-111615523-A | Process for preparing polymer compositions | 巴斯夫欧洲公司 | 2020-09-01 | — | — | CN | disclosed |
| EP-3016987-B1 | POLYMER COMPOSITION, OBTAINED BY POLYMERISATION OF A MONOMER CONTAINING ACID GROUPS IN THE PRESENCE OF A POLYETHER COMPOUND | BASF SE (DE) | 2020-06-03 | — | — | EP | disclosed |
| EP-3016986-B1 | POLYMER COMPOSITION, OBTAINED BY POLYMERISATION OF A MONOMER CONTAINING ACID GROUPS IN THE PRESENCE OF A POLYETHER COMPOUND | BASF SE (DE) | 2020-06-03 | — | — | EP | disclosed |
| US-10655088-B2 | Solid polymer composition obtained by polymerization of an acid group-containing monomer in the presence of a polyether compound | BASF SE (DE) | 2020-05-19 | — | — | US | disclosed |
| EP-1674485-A1 | Process for preparing polyvinylalcohol-polyether graft-copolymers by extrusion | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-28 | — | — | EP | disclosed |
| EP-1656111-A1 | COSMETIC AND PHARMACEUTICAL SUBSTANCES BASED ON POLYELECTROLYTE COMPLEXES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-17 | — | — | EP | disclosed |
| WO-2006045508-A1 | ANIONIC ETHYL METHACRYLATE COPOLYMERS AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006045510-A1 | AMPHOTERIC ETHYL METHACRYLATE COPOLYMERS AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006045509-A1 | COSMETIC PREPARATIONS CONTAINING COPOLYMERS OF ETHYL METHACRYLATE AND AT LEAST ONE MONOETHYLENICALLY UNSATURATED CARBOXYLIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006010571-A1 | CROSS-LINKED POLYTETRAHYDROFURAN-CONTAINING POLYURETHANES | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-02 | — | — | WO | disclosed |
| WO-2005123014-A1 | AQUEOUS PREPARATIONS COMPRISING A WATER-SOLUBLE OR WATER-DISPERSIBLE COPOLYMER WHICH CONTAINS AT LEAST ONE MONOMER HAVING A NITROGEN ATOM | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-29 | — | — | WO | disclosed |
| WO-2005058989-A1 | COPOLYMERS BASED ON TERT-BUTYL(METH)ACRYLATE AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-30 | — | — | WO | disclosed |
| WO-2005058988-A1 | AMPHOLYTIC ANIONIC COPOLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-30 | — | — | WO | disclosed |
| WO-2005004821-A1 | COSMETIC AND PHARMACEUTICAL SUBSTANCES BASED ON POLYELECTROLYTE COMPLEXES | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10655088-B2 | Solid polymer composition obtained by polymerization of an acid group-containing monomer in the presence of a polyether compound | PCCA, EEF1D, COPE | LMNA 330/4885ZDHHC20 1530/4885ZDHHC2 1202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.